Koyfin Home > Directory > Health Care > Revance Therapeutics > Return on Capital %

Revance Therapeutics Return on Capital % Chart (RVNC)

Revance Therapeutics annual/quarterly Return on Capital % from 2013 to 2020.
  • Revance Therapeutics Return on Capital % for the quarter ending June 06, 2020 was -29.56 a -79.55% increase of 23.51 year over year
  • Revance Therapeutics Return on Capital % for the last 12 months ending June 06, 2020 was -38.18 a -41.16% increase of 15.71 year over year
  • Revance Therapeutics Annual Return on Capital % for 2019 was -51.34 a 16.58% decrease of -8.51 from 2018
  • Revance Therapeutics Annual Return on Capital % for 2018 was -42.82 a 24.31% decrease of -10.41 from 2017
  • Revance Therapeutics Annual Return on Capital % for 2017 was -32.41 a 31.27% decrease of -10.13 from 2016
Other Margins & Efficiency Metrics:
  • Revance Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -67.02 a -4.32% increase of 2.89 year over year
View Chart On Koyfin

Quarterly RVNC Return on Capital % Data

06/2020-29.56
03/2020-39.95
12/2019-52.92
09/2019-53.08
06/2019-41.44
03/2019-45.98
12/2018-58.59
09/2018-42.91
06/2018-39.02
03/2018-35.08

Annual RVNC Return on Capital % Data

2019-51.34
2018-42.82
2017-32.41
2016-22.28
2015-20.47
2014-37.59
2013223.94
20121,062.65